NASDAQ:MBOT Microbot Medical (MBOT) Stock Price, News & Analysis → Trump’s “Tax Free” Retirement Strategy (From Gold Safe Exchange) (Ad) Free MBOT Stock Alerts $1.15 +0.02 (+1.77%) (As of 03/27/2024 ET) Add Compare Share Share Today's Range$1.13▼$1.1850-Day Range$1.09▼$1.4052-Week Range$1.00▼$4.37Volume29,452 shsAverage Volume120,554 shsMarket Capitalization$13.47 millionP/E RatioN/ADividend YieldN/APrice Target$8.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Get Microbot Medical alerts: Email Address Microbot Medical MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside595.7% Upside$8.00 Price TargetShort InterestHealthy0.77% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.43Based on 3 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($1.09) to ($0.64) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.2.07 out of 5 starsMedical Sector746th out of 939 stocksSurgical & Medical Instruments Industry77th out of 96 stocks 3.5 Analyst's Opinion Consensus RatingMicrobot Medical has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $8.00, Microbot Medical has a forecasted upside of 595.7% from its current price of $1.15.Amount of Analyst CoverageMicrobot Medical has received no research coverage in the past 90 days. Previous Next 3.0 Short Interest Percentage of Shares Shorted0.77% of the outstanding shares of Microbot Medical have been sold short.Short Interest Ratio / Days to CoverMicrobot Medical has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Microbot Medical has recently increased by 300.00%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldMicrobot Medical does not currently pay a dividend.Dividend GrowthMicrobot Medical does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for MBOT. Previous Next 2.5 News and Social Media Coverage News SentimentMicrobot Medical has a news sentiment score of 0.43. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.65 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Microbot Medical this week, compared to 1 article on an average week.MarketBeat Follows2 people have added Microbot Medical to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days. Previous Next 0.8 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Microbot Medical insiders have not sold or bought any company stock.Percentage Held by Insiders10.64% of the stock of Microbot Medical is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 16.30% of the stock of Microbot Medical is held by institutions. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Microbot Medical are expected to grow in the coming year, from ($1.09) to ($0.64) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Microbot Medical is -0.96, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Microbot Medical is -0.96, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Gold Safe ExchangeTrump’s “Tax Free” Retirement Strategy Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.Protect your retirement savings from the inevitable devaluation of the dollar… About Microbot Medical Stock (NASDAQ:MBOT)Microbot Medical Inc. operates as a pre-clinical medical device company in the United Kingdom. It primarily engages in the research, design, and development of next generation robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company also offers LIBERTY, a robotic system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination. In addition, it provides One & Done Technology, an endovascular robotic system for a range of applications in cardiovascular, peripheral vascular, and neurovascular spaces; and NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. Further, the company offers ViRob, an autonomous crawling micro-robot which can be controlled remotely to navigate and crawl in different natural spaces within the human body, including blood vessels, digestive tract, and respiratory system, as well as artificial spaces, such as shunts, catheters, ports, etc. Additionally, it provides ipCAT, a disposable self-propelled locomotive device that is designed to advance in tubular anatomies. The company also has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is headquartered in Hingham, Massachusetts.Read More MBOT Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart MBOT Stock News HeadlinesMarch 27, 2024 | investorplace.comMBOT Stock Earnings: Microbot Medical Misses EPS for Q4 2023March 16, 2024 | ca.finance.yahoo.comMBOT Apr 2024 3.000 callMarch 28, 2024 | Gold Safe Exchange (Ad)Trump’s “Tax Free” Retirement Strategy Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.February 26, 2024 | benzinga.comMicrobot Medical Stock (NASDAQ:MBOT) Dividends: History, Yield and DatesFebruary 21, 2024 | finance.yahoo.comMBOT Jul 2024 2.500 putFebruary 21, 2024 | finance.yahoo.comMBOT Apr 2024 5.000 callFebruary 18, 2024 | finance.yahoo.comMBOT Mar 2024 2.500 callFebruary 5, 2024 | finanznachrichten.deMicrobot Medical Inc.: Microbot Medical Submits an IDE Application to Gain FDA Approval to Commence Its Pivotal Clinical Trial in the USMarch 28, 2024 | Gold Safe Exchange (Ad)Trump’s “Tax Free” Retirement Strategy Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.February 5, 2024 | msn.comMicrobot files FDA application for clinical study of Liberty systemFebruary 5, 2024 | finance.yahoo.comMicrobot Medical Submits an IDE Application to Gain FDA Approval to Commence Its Pivotal Clinical Trial in the USFebruary 2, 2024 | benzinga.comLooking Into Microbot Medical's Recent Short InterestJanuary 31, 2024 | msn.comMicrobot Medical Settles: Regulation FD Disclosure UpdateJanuary 30, 2024 | finanznachrichten.deMicrobot Medical Inc.: Microbot Medical Announces Settlement and Release Agreement, Effectively Resolving all Associated Legal MattersJanuary 30, 2024 | msn.comMicrobot Medical announces settlement resolving legal mattersJanuary 30, 2024 | finance.yahoo.comMicrobot Medical Announces Settlement and Release Agreement, Effectively Resolving all Associated Legal MattersJanuary 18, 2024 | finance.yahoo.comMicrobot Medical Expands US Clinical Infrastructure in Support of the Upcoming IDE Submission to Commence its First in Human Clinical StudyDecember 29, 2023 | marketwatch.comMicrobot Medical Shares Drop 20% After Exercising Investment OptionsDecember 29, 2023 | msn.comGold Moves Lower; Microbot Medical Shares SlideDecember 29, 2023 | msn.comMicrobot Medical down 22%, exercises investment options for $2.73M proceedsDecember 29, 2023 | finance.yahoo.comMicrobot Medical Announces Exercise of Outstanding Preferred Investment Options for $2.73 Million in Gross Proceeds Priced At-the-Market Under Nasdaq RulesDecember 28, 2023 | msn.comMicrobot to advance Liberty Robotic System into pivotal clinical trialDecember 28, 2023 | markets.businessinsider.comMicrobot Medical Announces Positive Results For GLP Pivotal Pre-Clinical Study; Stock Up 15%December 28, 2023 | msn.comMicrobot Medical Stock Is Moving Higher: What's Going On?December 28, 2023 | finance.yahoo.comMicrobot Medical Announced Positive Results of Its GLP Pivotal Pre-Clinical Study Where All Study Objectives Were MetDecember 20, 2023 | fool.comMicrobot Medical (NASDAQ: MBOT)December 14, 2023 | markets.businessinsider.comMicrobot Medical Collaborates With Corewell Health To Enable Telerobotics Between Remote CentersSee More Headlines Receive MBOT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Microbot Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/15/2021Today3/28/2024Next Earnings (Estimated)3/29/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryN/A Current SymbolNASDAQ:MBOT CUSIPN/A CIK883975 Webwww.microbotmedical.com Phone(781) 875-3605Fax781-556-5347Employees18Year Founded2010Price Target and Rating Average Stock Price Target$8.00 High Stock Price Target$8.00 Low Stock Price Target$8.00 Potential Upside/Downside+595.7%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)($1.20) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-13,170,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-146.17% Return on Assets-119.20% Debt Debt-to-Equity RatioN/A Current Ratio5.64 Quick Ratio5.64 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares11,710,000Free Float10,461,000Market Cap$13.47 million OptionableOptionable Beta1.65 Social Links A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for April 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesMr. Harel Gadot (Age 51)Co-Founder, President, CEO & Chairman Comp: $770.35kMr. Yoseph Bornstein (Age 65)Co-Founder & Independent Director Comp: $13.12kMs. Rachel Vaknin (Age 45)Chief Financial Officer Comp: $212.97kDr. Simon Sharon MBA (Age 64)MSc, CTO & GM of Microbot Israel Comp: $381.51kProf. Moshe Shoham D.Sc. (Age 72)Co-Founder, Scientific Director & Chairman of Scientific Advisory Board Comp: $33.33kDr. Juan Diaz-CartelleChief Medical OfficerMore ExecutivesKey CompetitorsBiotricityNASDAQ:BTCYIntelligent Bio SolutionsNASDAQ:INBST2 BiosystemsNASDAQ:TTOOAcorda TherapeuticsNASDAQ:ACORNEXGELNASDAQ:NXGLView All CompetitorsInstitutional OwnershipVanguard Group Inc.Bought 198,213 shares on 3/11/2024Ownership: 3.924%Virtu Financial LLCBought 18,138 shares on 2/26/2024Ownership: 0.359%Vanguard Group Inc.Bought 198,213 shares on 2/15/2024Ownership: 3.924%Citadel Advisors LLCBought 1,600 shares on 2/15/2024Ownership: 0.000%Armistice Capital LLCBought 300,000 shares on 2/13/2024Ownership: 2.562%View All Institutional Transactions MBOT Stock Analysis - Frequently Asked Questions Should I buy or sell Microbot Medical stock right now? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Microbot Medical in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" MBOT shares. View MBOT analyst ratings or view top-rated stocks. What is Microbot Medical's stock price target for 2024? 1 Wall Street analysts have issued 1-year target prices for Microbot Medical's stock. Their MBOT share price targets range from $8.00 to $8.00. On average, they predict the company's share price to reach $8.00 in the next year. This suggests a possible upside of 595.7% from the stock's current price. View analysts price targets for MBOT or view top-rated stocks among Wall Street analysts. How have MBOT shares performed in 2024? Microbot Medical's stock was trading at $1.64 at the start of the year. Since then, MBOT stock has decreased by 29.9% and is now trading at $1.15. View the best growth stocks for 2024 here. Are investors shorting Microbot Medical? Microbot Medical saw a increase in short interest in the month of March. As of March 15th, there was short interest totaling 89,600 shares, an increase of 300.0% from the February 29th total of 22,400 shares. Based on an average daily volume of 892,800 shares, the days-to-cover ratio is presently 0.1 days. View Microbot Medical's Short Interest. When is Microbot Medical's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Friday, March 29th 2024. View our MBOT earnings forecast. How were Microbot Medical's earnings last quarter? Microbot Medical Inc. (NASDAQ:MBOT) released its quarterly earnings results on Monday, November, 15th. The biotechnology company reported ($0.36) earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of ($0.36). When did Microbot Medical's stock split? Microbot Medical's stock reverse split before market open on Monday, May 9th 2016. The 1-12 reverse split was announced on Friday, May 6th 2016. The number of shares owned by shareholders was adjusted after the closing bell on Friday, May 6th 2016. An investor that had 100 shares of stock prior to the reverse split would have 8 shares after the split. What other stocks do shareholders of Microbot Medical own? Based on aggregate information from My MarketBeat watchlists, some companies that other Microbot Medical investors own include Advanced Micro Devices (AMD), Athersys (ATHX), NVIDIA (NVDA), Gilead Sciences (GILD), Inovio Pharmaceuticals (INO), Novavax (NVAX), Pfizer (PFE), Micron Technology (MU) and Sorrento Therapeutics (SRNE). Who are Microbot Medical's major shareholders? Microbot Medical's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (3.92%), Vanguard Group Inc. (3.92%), Armistice Capital LLC (2.56%), Virtu Financial LLC (0.36%), Citadel Advisors LLC (0.00%) and Cutler Group LLC CA (0.00%). View institutional ownership trends. How do I buy shares of Microbot Medical? Shares of MBOT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:MBOT) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyBREAKING: New AI Breakthrough Could Change Healthcare ForeverBehind the Markets“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisorySHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceBuy this small stock before coming AI Tidal WaveChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Microbot Medical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.